Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: OK, what we have learned today

OK, what we have learned today

posted on Mar 09, 2006 04:36PM
1. dividends could be par for the course.

2. company is on course and agreements could be in the works still, however maybe slower than some wish.

3. We don`t have the cash yet on the last deals, so that answers that 8k question, so don`t look so quick next time for the $ to be handed over from TPL right along with the anouncement of a deal.

4. We suspect the compnay is looking foward to this years

SHM.

5. We are a happy bunch of baby sa-boomers.

Share
New Message
Please login to post a reply